Video Experimental Relacionado
Updated: Sep 10, 2025
07:01
Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
Published on: May 16, 2019
9.2K
[Diagnóstico y tratamiento de la epilepsia: desde el control de las convulsiones hasta la intervención dirigida]
1Department of Neurology, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Zhonghua yi xue za zhi
|August 24, 2025
Resumen
La medicina de precisión está revolucionando el tratamiento de la epilepsia, yendo más allá del control de los síntomas. Las nuevas tecnologías como los organoides cerebrales y la IA ofrecen terapias personalizadas y modificación de la enfermedad para la epilepsia resistente a los medicamentos.
Área de la Ciencia:
- Neurología
- Biotecnología
- Tecnología médica
Sus antecedentes:
- El manejo de la epilepsia está cambiando del control de las convulsiones a la medicina de precisión debido a las limitaciones de los medicamentos anticonvulsivos actuales, con un tercio de los pacientes desarrollando epilepsia resistente a los medicamentos.
- Los tratamientos tradicionales tratan principalmente los síntomas, lo que requiere enfoques innovadores para la modificación de la enfermedad.
Objetivo del estudio:
- Explorar el cambio de paradigma en el manejo de la epilepsia hacia la medicina de precisión.
- Destacar las tecnologías innovadoras que permiten terapias personalizadas y modificadoras de la enfermedad de la epilepsia.
- Esbozar las direcciones futuras para avanzar en el tratamiento de la epilepsia.
Principales métodos:
- Utilizando la tecnología de organoides cerebrales para modelar la epilepsia genética y el cribado personalizado de medicamentos.
- El uso de imágenes de redes cerebrales multimodales para identificar las características de las redes neuronales de la epilepsia.
- Aplicación de la predicción de objetivos de fármacos impulsada por inteligencia artificial (IA), administración de nanofármacos y edición de genes.
Principales resultados:
- Los organoides cerebrales modelan eficazmente las características genéticas de la epilepsia, ayudando a la detección personalizada de medicamentos y al desarrollo de terapias modificadoras de la enfermedad.
- La imagen cerebral multimodal revela las características de la red neuronal de la epilepsia, guiando las intervenciones basadas en la red.
- La IA, los sistemas de nanoentrega y la edición de genes presentan nuevas estrategias para intervenir en la progresión de la epilepsia.
Conclusiones:
- El tratamiento de la epilepsia está evolucionando hacia la medicina de precisión y la modificación de la enfermedad, impulsado por los avances tecnológicos.
- Los avances en tecnología de organoides, neuroimagen, IA y edición de genes ofrecen nuevas esperanzas terapéuticas.
- Los biomarcadores estandarizados, los estudios del mundo real y las directrices optimizadas son cruciales para el progreso futuro.
Más Videos Relacionados
12:10Performing Behavioral Tasks in Subjects with Intracranial Electrodes
Published on: October 2, 2014
11.5K
09:00Investigating the Function of Deep Cortical and Subcortical Structures Using Stereotactic Electroencephalography: Lessons from the Anterior Cingulate Cortex
Published on: April 15, 2015
12.4K
Videos de Conceptos Relacionados
01:24Epilepsy and Seizures: Overview
277
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
277
01:13Seizures: Classification
586
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
586
01:08Antiepileptic Drugs: Sodium Channel Blockers
875
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
875
01:14Antiepileptic Drugs: Glutamate Antagonists
512
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
512
01:30Electroconvulsive Therapy
185
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
185
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
640
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
640